MAbxience Opens 'Unique' Biosimilars Manufacturing Facility
This article was originally published in Scrip
Executive Summary
Biosimilar drug developer, MAbxience, has opened a new manufacturing plant in Léon, Spain – marking one of the largest investments by a Spanish group in biotech in the country.